血清PCT与糖尿病不同病情程度相关性分析研究
[Abstract]:BACKGROUND: The onset and treatment of diabetes (Diabetes Mellitus, DM) has become a major problem in the safety of human population, and the difficulty in the treatment of DM is insufficient evidence in diagnosis and treatment, resulting in insufficient or excessive treatment. The bidirectionality of inflammation and its function acts as a defensive and destructive role in the body, and the persistent high basal level of inflammation in the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the course of the However, it is still not possible to have an effective and extensive application in clinical application, and the specific reason may be related to the number of involved types of inflammation and the interaction. Procalcitonin (PCT) has been found to be a pre-peptide substance without hormone activity, and the external stability of procalcitonin (PCT) is very good. In recent years, the clinical application value of PCT is mainly the early prediction and evaluation of bacterial infection and systemic inflammatory response, and the clinical data confirm that PCT has an important role in the assessment of the severity of bacterial inflammation and the evaluation of the effect of antibacterial and prognosis. due to the fact that it has certain tissue specificity and wide expression, it is suggested that this index may have the diagnostic value of the application other than the diagnosis and treatment of bacterial infection, and in recent years basic research and clinical observation have found, The PCT also has the value of the judgment of the degree of the condition of the aseptic inflammation and the evaluation value of the degree of tissue injury, and the correlation between the PCT and the inflammatory factors has found that the PCT also has the ability to comprehensively reflect the inflammatory factors. These previous studies have found that the ability of PCT to reflect the inflammatory injury and the need for diagnosis and treatment of diabetes do not match. Objective: To compare the expression of procalcitonin (PCT) in the patients with diabetes (Diabetes Mellitus, DM), and to compare the correlation between the correlation of PCT and the pathogenesis of diabetes and the degree of diabetes. It is suggested that PCT has a certain value for the diagnosis of diabetes. Methods:878 diabetic patients were selected to study the PCT? TNF-1 in patients with different degree of infection. IL-6? INF-1 level; combined infection diagnosis, fasting blood glucose (FBG) and glycosylated hemoglobin (Hb), urinary microalbumin (UmAlb), acute venereal disease physiology and long-term health evaluation II (AACHEII: Aute Physiology and Chronic Health Evaluation II) did not have complications in the early stage of DM, The severity of the chronic complications and the acute complications was graded, and the condition of the disease was assessed with PCT? TNF-1? The expression level of IL-6? INF-1. Results:1. PCT expression in DM patients increased with the severity of the course of the disease, and the level of PCT basal expression in DM patients was higher than that of normal controls, and the level of PCT expression in patients with acute complication was the highest, while the level of PCT expression in early DM group was the lowest. The difference of PCT expression is up-regulated with the severity of the disease, and other inflammatory markers TNF-1? IL-6, INF-1 showed up-regulation of non-infection and local infections with a lower severity of early and chronic complications of DM, There were no significant changes in the level of PCT expression in DM patients and the severity of the disease, and the level of PCT in DM patients was higher than that of normal controls (0.1 to 0.05 ng/ ml). The correlation of the disease grade index and the PCT and other relevant inflammation indexes of different stages was found, in the early period of no complications, chronic complications and acute concurrent DM patients, PCT? TNF-1? IL-6 showed a difference in expression in each group; INF-6 showed a difference in expression only in patients with no complications and chronic complications in the early stage of DM (lower HbA1c%/ FPG grade score), while the level of expression in patients with systemic infection was lower than that of normal controls (8.31% 2.87 pg/ ml). The correlation analysis found that the inflammatory factor PCT? TNF-1? IL-6? INF-1 showed a different degree of correlation in different degree of disease. There is a correlation between IL-6? INF-1, which is associated with TNF-1? There was a positive correlation between IL-6 and negative correlation with INF-6, but the statistical analysis of the correlation between chronic and acute complications with high degree of inflammation was poor. In patients with lower levels of Hb%%/ FPG, PCT? TNF-1? There was a correlation between IL-6? INF-1 and the grade of the disease, which was related to PCT? TNF-1? IL-6 showed positive correlation and negative correlation with INF-6. In patients with DM acute complications according to the APACHEII score, patients with a score of less than 15 PCT? TNF-1? IL-6? INF-1 showed a correlation, whereas in patients with a score of 15, the correlation was poor and there was a low correlation between the PCT and the table. Conclusion: The level of PCT expression in DM patients is a response to the severity of the disease, especially the degree of inflammation, and PCT may be of great reference value to the diagnosis and treatment of the severity of the disease.
【学位授予单位】:第三军医大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R587.1
【参考文献】
相关期刊论文 前10条
1 高勇;梅丽;王晓静;牛艳慧;王钧;;重度缺血性卒中无感染患者的降钙素原动态变化[J];河北医科大学学报;2015年08期
2 Adam M Noyes;Kirandeep Dua;Ramprakash Devadoss;Lovely Chhabra;;Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease[J];World Journal of Diabetes;2014年06期
3 周菲;冯玉;;糖尿病患者酮症酸中毒降钙素原水平的变化[J];中国老年学杂志;2014年17期
4 Montserrat B Duran-Salgado;Alberto F Rubio-Guerra;;Diabetic nephropathy and inflammation[J];World Journal of Diabetes;2014年03期
5 万泽民;陈伟烨;卢妙莲;周海涛;高云龙;张成;韩光;唐小龙;黄旭东;;糖尿病肾病患者血清降钙素原水平及与其它指标间的关系[J];四川大学学报(医学版);2014年03期
6 徐定华;石秋萍;王超;王红;张淑文;;降钙素原在感染性疾病诊断中应用价值的临床病例分析[J];临床和实验医学杂志;2014年08期
7 张玲;郝艳梅;张世益;马晓兰;;PCT和IL-6在感染性疾病中的诊断价值[J];放射免疫学杂志;2012年05期
8 郑丽;徐涛;;糖尿病研究进展[J];生命科学;2012年07期
9 洪训宇;;定量检测PCT、CRP在产科ICU患者感染诊断及预后判断中的应用评价[J];中国卫生检验杂志;2012年03期
10 杨升华;尹卫东;;氧化应激与糖尿病研究进展[J];微量元素与健康研究;2011年03期
,本文编号:2486676
本文链接:https://www.wllwen.com/yixuelunwen/nfm/2486676.html